Skip to main navigation Skip to search Skip to main content

Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists

  • Jason Younkin
  • , Supriya A. Gaitonde
  • , Amr Ellaithy
  • , Rakesh Vekariya
  • , Lia Baki
  • , José L. Moreno
  • , Sneha Shah
  • , Peter Drossopoulos
  • , Kelsey S. Hideshima
  • , Jose Miguel Eltit
  • , Javier González-Maeso
  • , Diomedes E. Logothetis
  • , Malgorzata Dukat
  • , Richard A. Glennon

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Several pharmacophore models have been proposed for 5-HT2A serotonin receptor antagonists. These typically consist of two aromatic/hydrophobic moieties separated by a given distance from each other, and from a basic amine. Although specified distances might vary, the models are relatively similar in their general construction. Because our preliminary data indicated that two aromatic (hydrophobic) moieties might not be required for such action, we deconstructed the serotonin-dopamine antipsychotic agent risperidone (1) into four smaller structural fragments that were thoroughly examined in 5-HT2A receptor binding and functional (i.e., two-electrode voltage clamp (TEVC) and intracellular calcium release) assays. It was apparent that truncated risperidone analogues behaved as antagonists. In particular, 6-fluoro-3-(1-methylpiperidin-4-yl)benzisoxazole (4) displayed high affinity for 5-HT2A receptors (Ki of ca. 12 nM) relative to risperidone (Ki of ca. 5 nM) and behaved as a potent 5-HT2A serotonin receptor antagonist. These results suggest that multiple aromatic (hydrophobic) moieties are not essential for high-affinity 5-HT2A receptor binding and antagonist activity and that current pharmacophore models for such agents are very much in need of revision.

Original languageEnglish
Pages (from-to)1292-1299
Number of pages8
JournalACS Chemical Neuroscience
Volume7
Issue number9
DOIs
StatePublished - 21 Sep 2016
Externally publishedYes

Keywords

  • 3-(4-piperidinyl)benzisoxazoles
  • Risperidone
  • TEVC (two-electrode voltage clamp)
  • antipsychotics
  • calcium release

Fingerprint

Dive into the research topics of 'Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists'. Together they form a unique fingerprint.

Cite this